Gene Marker Suggests Likelihood of Prostate Cancer Metastasizing
Researchers have found a genetic signature that can forecast whether cancer is likely to metastasize or spread in the early stages of localized prostate cancer. The signature can also predict whether the disease will respond to anti-androgen therapy. In addition, the new signature may be beneficial in helping evaluate the disease’s response to treatment as well as creating new treatments to treat or avert the advanced stages of prostate cancer. This groundbreaking study was reported in “Nature Cancer.” A professor of cell biology and pathology in Columbia University’s Irving Medical Center, Cory-Abate-Shen, senior author of the study, states that if…











